Search

everythinglearnresearchcommunity

for

Search:↓

Different hair loss patterns may be linked to varying male hormone levels.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Over half of the adult women with acne in the study had higher than normal levels of male hormones, especially DHEA.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Low prolactin in young women may increase heart and metabolism risks.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

Overweight women with PCOS are more likely to have excess male hormones.

A woman developed male traits from accidental contact with her husband's testosterone gel.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

Testosterone treatment may change estrogen receptor methylation in AFAB individuals.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Combining spironolactone with metformin reduces insulin resistance in PCOS better than either drug alone.

The woman's high testosterone levels indicated PCOS, leading to treatment that improved her symptoms.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

Cyclosporine A therapy changes sex hormone levels differently in pre-menopausal and post-menopausal women with primary biliary cirrhosis.

Feminizing hormone therapy increases hair counts and improves hair-related quality of life, while masculinizing therapy may reduce large terminal hairs.

PCOS often causes acne, dark skin patches, excess hair, and hair loss, linked to hormone levels and obesity.

Clomiphene Citrate can quickly restore fertility in some men after long-term steroid abuse.

An unusual growth of Leydig cells in a woman's ovaries caused her excessive hair growth, which was treated successfully with surgery.